Сравнитильный анализ эффективности плазменных трансуретральных методов лечения доброкачественной гиперплазии предстательной железы
DOI:
https://doi.org/10.25726/NM.2019.49.40.004Ключевые слова:
доброкачественная гиперплазия предстательной железы, плазмокинетическая трансуретральная резекция, плазмокинетическая трансуретральная энуклеация, открытая простатэктомия, кровопотеря, оперативное лечениеАннотация
В статье представлено сравнительное исследование результатов применения плазменных эндоскопических технологий и открытой простатэктомии в лечении доброкачественной гиперплазии предстательной железы (ДГПЖ) средних и больших размеров.
Базой, на которой было проведено исследование, явился Центр эндоурологии ГАУЗ ГКБ №7, город Казань. Оценка периоперационных результатов эндоскопических методов лечения ДГПЖ был проведен на основе текущего наблюдения за период 2015-2018 годы.
При равной хирургической эффективности методов коллективом авторов установлено, что использование эндоуретральных методик дает достоверное снижение количества интра- и послеоперационных осложнений. Уменьшение геморрагических и инфекционно-воспалительных осложнений во время операции и в раннем послеоперационном периоде приводит к сокращению сроков дренирования мочевого пузыря и продолжительности госпитализации. Применение современного оборудования, функционирующего на платформе "ПЛАЗМА", в сравнении с ранее используемым оборудованием для биполярных операций позволяет сократить время оперативного вмешательства при выполнении эндоскопической энуклеации.
Выявленные преимущества трансуретральных методов лечения ДГПЖ свидетельствует о более высоком профиле их безопасности и эффективности, что дает основание для включения плазмокинетических эндоуретральных методов операций в стандарт урологического лечения пациентов данного профиля.
Библиографические ссылки
1. Apolikhin O.I., Sivkov A.V., Beshliev D.A., Solntseva T.V., Komarova V.A., Zaitsevskaya E.V. Analysis of urological morbidity in the Russian Federation in 2002-2009 according to official statistics. Experimental and clinical urology. 2011. No1. S. 4-10.
2. Danilov VV, Osinkin KS, Danilov VV, Sevryukov F.A. Alpha1-blockers and detrusor hyperactivity in patients with prostate adenoma. Questions of urology and andrology. 2018.Vol. 6. No. 2. P. 49-53.
3. Ilchenko G.V., Ischenko O.Yu., Lynova E.N., Prishchep L.V. Assessment of organizational loyalty in medical institutions. International Journal of Medicine and Psychology. 2018. Volume 1. No. 4. S. 24-35.
4. Kamyshov S.V., Pulatov D.A., Yuldasheva N.Sh., Balenkov O.Yu. Study of the influence of immunotherapy methods on peroxidation processes in the accompanying treatment of cervical cancer. Eurasian Oncology Journal. 2015. No. 4 (7). S. 60-66.
5. Kulikova N.G., Kamurzoeva S.Sh. Medical and social characteristics of patients of working age with primary disability. Problems of social hygiene, health care and the history of medicine. 2014.Vol. 22. No. 2. P. 14-16.
6. Pulatov D.A., Ibragimov Zh.M., Kamyshov S.V. Comparative evaluation of the toxicity of treatment of patients with chemoresistant colorectal cancer. Oncology and radiology of Kazakhstan. 2017. No. 2 (44). S. 58-61.
7. Salalykina E.V., Papikyan O.A. Issues of optimizing the work of paramedical personnel in a central district hospital. International Journal of Medicine and Psychology. 2018. Volume 1. No. 2. S. 12-16.
8. Sevryukov F.A. The quality of life of patients after transurethral enucleation of large prostate adenomas. Andrology and genital surgery. 2012. T. 13. No. 3. P. 42-46.
9. Sevryukov F.A. Transurethral resection in saline. Urology. 2012. No. 2. P. 67-70.
10. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Mushroom M.N., Perevezentsev E.A. The social status of patients suffering from benign prostatic hyperplasia. Public health and healthcare. 2011. No 1. S. 53-56.
11. Sevryukov F.A., Malinina O.Yu. New organizational technologies for providing medical care to patients with benign prostatic hyperplasia. Social aspects of public health. 2012. V. 23. No. 1. S. 1-7.
12. Sevryukov F.A., Puchkin A.B., Krupin V.N., Chebykin A.V., Sorokin D.A., Karpukhin I.V., Malinina O.Yu., Zorin D.G. New Generation Transurethral Electrosurgery (TURIS) in the treatment of diseases of the lower urinary tract and prostate. Urology. 2007. No. 3. P. 28-35.
13. Sevryukov F.A., Serebryany S.A. A case of successful transurethral enucleation of prostate adenoma is very large. Andrology and genital surgery. 2012.V. 13. No. 3. S. 101-103.
14. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D. Experience with the use of bipolar vapor resection of the prostate gland (TUVRB) in the treatment of BPH. Experimental and clinical urology. 2014. No. 2. P. 49-53.
15. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. Comparative evaluation of the effectiveness of various energy blocks in bipolar prostate surgery. Pacific Medical Journal. 2017. No. 1 (67). S. 88-90.
16. Sorokin D.A., Sevryukov F.A., Semenychev D.V., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. The results of the use of hyaluronic acid after transurethral endoscopic surgery for benign prostatic hyperplasia. Medical Bulletin of Bashkortostan. 2015.V. 10. No. 3. P. 19-24.
17. Urology. Russian Clinical Recommendations, ed. Yu. G. Alyaev, P.V. Glybochko, D. Yu. Pushkar. M.: GEOTAR-Media, 2016.496 s.
18. Khamurzoeva S.Sh., Kulikova N.G. Ways to reduce disability in people of working age. Problems of social hygiene, health care and the history of medicine. 2013. No. 6. S. 29-31.
19. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial–the Goliath study Eur Urol. 2014. 65(5):931-942
20. da Silva R.D., Bidikov L., Michaels W. et al. Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol 2015;22 Suppl 1:30-44.
21. EAU guidelines on the treatment and follow-up of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction M. Oelke [et al.]. European Urology. 2013. Vol. 64, № 1. P. 118-140.
22. Geavlete B, Stanescu F, Iacoboaie C, Geavlete P. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - A medium term, prospective, randomized comparison. BJU Int. 2013 May;111(5):793-803.
23. Lee Y.T., Ryu Y.W., Lee D.M. at al. Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral Resection of the Prostate in Saline (TURIS), and TURIS-Plasma Vaporization for the Treatment of BPH: A Pilot Study. Korean J Urol. 2011. Nov; 52(11). Р. 763-8.
24. Nakagava, K. A new minimally invasive medical treatment for prostatic hyperplasia: its current situation and actual practice of the operation; TUEB. K. Nakagava. Urology View. 2007. Vol. 5. P. 95-97.
25. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008. 180(1):246-249.
26. Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D et al Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002. 60(4):623-627
27. Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prost
2. Danilov VV, Osinkin KS, Danilov VV, Sevryukov F.A. Alpha1-blockers and detrusor hyperactivity in patients with prostate adenoma. Questions of urology and andrology. 2018.Vol. 6. No. 2. P. 49-53.
3. Ilchenko G.V., Ischenko O.Yu., Lynova E.N., Prishchep L.V. Assessment of organizational loyalty in medical institutions. International Journal of Medicine and Psychology. 2018. Volume 1. No. 4. S. 24-35.
4. Kamyshov S.V., Pulatov D.A., Yuldasheva N.Sh., Balenkov O.Yu. Study of the influence of immunotherapy methods on peroxidation processes in the accompanying treatment of cervical cancer. Eurasian Oncology Journal. 2015. No. 4 (7). S. 60-66.
5. Kulikova N.G., Kamurzoeva S.Sh. Medical and social characteristics of patients of working age with primary disability. Problems of social hygiene, health care and the history of medicine. 2014.Vol. 22. No. 2. P. 14-16.
6. Pulatov D.A., Ibragimov Zh.M., Kamyshov S.V. Comparative evaluation of the toxicity of treatment of patients with chemoresistant colorectal cancer. Oncology and radiology of Kazakhstan. 2017. No. 2 (44). S. 58-61.
7. Salalykina E.V., Papikyan O.A. Issues of optimizing the work of paramedical personnel in a central district hospital. International Journal of Medicine and Psychology. 2018. Volume 1. No. 2. S. 12-16.
8. Sevryukov F.A. The quality of life of patients after transurethral enucleation of large prostate adenomas. Andrology and genital surgery. 2012. T. 13. No. 3. P. 42-46.
9. Sevryukov F.A. Transurethral resection in saline. Urology. 2012. No. 2. P. 67-70.
10. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Mushroom M.N., Perevezentsev E.A. The social status of patients suffering from benign prostatic hyperplasia. Public health and healthcare. 2011. No 1. S. 53-56.
11. Sevryukov F.A., Malinina O.Yu. New organizational technologies for providing medical care to patients with benign prostatic hyperplasia. Social aspects of public health. 2012. V. 23. No. 1. S. 1-7.
12. Sevryukov F.A., Puchkin A.B., Krupin V.N., Chebykin A.V., Sorokin D.A., Karpukhin I.V., Malinina O.Yu., Zorin D.G. New Generation Transurethral Electrosurgery (TURIS) in the treatment of diseases of the lower urinary tract and prostate. Urology. 2007. No. 3. P. 28-35.
13. Sevryukov F.A., Serebryany S.A. A case of successful transurethral enucleation of prostate adenoma is very large. Andrology and genital surgery. 2012.V. 13. No. 3. S. 101-103.
14. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D. Experience with the use of bipolar vapor resection of the prostate gland (TUVRB) in the treatment of BPH. Experimental and clinical urology. 2014. No. 2. P. 49-53.
15. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. Comparative evaluation of the effectiveness of various energy blocks in bipolar prostate surgery. Pacific Medical Journal. 2017. No. 1 (67). S. 88-90.
16. Sorokin D.A., Sevryukov F.A., Semenychev D.V., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. The results of the use of hyaluronic acid after transurethral endoscopic surgery for benign prostatic hyperplasia. Medical Bulletin of Bashkortostan. 2015.V. 10. No. 3. P. 19-24.
17. Urology. Russian Clinical Recommendations, ed. Yu. G. Alyaev, P.V. Glybochko, D. Yu. Pushkar. M.: GEOTAR-Media, 2016.496 s.
18. Khamurzoeva S.Sh., Kulikova N.G. Ways to reduce disability in people of working age. Problems of social hygiene, health care and the history of medicine. 2013. No. 6. S. 29-31.
19. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial–the Goliath study Eur Urol. 2014. 65(5):931-942
20. da Silva R.D., Bidikov L., Michaels W. et al. Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol 2015;22 Suppl 1:30-44.
21. EAU guidelines on the treatment and follow-up of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction M. Oelke [et al.]. European Urology. 2013. Vol. 64, № 1. P. 118-140.
22. Geavlete B, Stanescu F, Iacoboaie C, Geavlete P. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - A medium term, prospective, randomized comparison. BJU Int. 2013 May;111(5):793-803.
23. Lee Y.T., Ryu Y.W., Lee D.M. at al. Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral Resection of the Prostate in Saline (TURIS), and TURIS-Plasma Vaporization for the Treatment of BPH: A Pilot Study. Korean J Urol. 2011. Nov; 52(11). Р. 763-8.
24. Nakagava, K. A new minimally invasive medical treatment for prostatic hyperplasia: its current situation and actual practice of the operation; TUEB. K. Nakagava. Urology View. 2007. Vol. 5. P. 95-97.
25. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008. 180(1):246-249.
26. Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D et al Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002. 60(4):623-627
27. Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prost
Дополнительные файлы
Опубликован
2018-12-25
Как цитировать
Perchatkin, V. A., & Kasimov, M. R. (2018). Сравнитильный анализ эффективности плазменных трансуретральных методов лечения доброкачественной гиперплазии предстательной железы. Вопросы экологии, 8(4), 31–40. https://doi.org/10.25726/NM.2019.49.40.004
Выпуск
Раздел
Статьи
